Market closed·Syncing…
SMEMarket closed · Close · 18 Nov

Invicta Diagnostic Limited INVICTAshare price and chart

Invicta Diagnostic closed at ₹77.00 on 18 November 2026, down 2.41% on the day. The 52-week range is ₹58.10 to ₹105.00.

₹77.00The price one share last traded at, in rupees.▼ 2.41% · ₹1.90
52-wk low ₹5840% up the rangeThe highest and lowest price the share has traded at in the past year, and where today's price sits between the two.high ₹105

Daily candlesEach candle is one trading day. The chart opens on the last year; drag back past the start or open full screen and the rest loads, back to listing (or the first day in our data). The body runs from the open to the close, the thin lines to the high and low. Green closed up, red closed down.

Loading prices…

Split and bonus adjusted daily candles. Drag back past the start, or open full screen, and its whole history loads. Scroll or pinch to zoom; full screen adds indicators, drawing and measuring.

Test a strategy on INVICTA

Real prices, every charge counted. Pick one or write your own.
What Invicta Diagnostic Limited does
A short, human-reviewed summary of the business, written from public sources. Background, not analysis, and not updated intraday.
business summary

Invicta Diagnostic provides diagnostic services including MRI, CT, PET-CT, X-ray and sonography imaging, pathology tests, integrated diagnostics and teleradiology, through its own centres and subsidiaries in a hub and spoke model.

1
1Sector

Healthcare Services

2
2What it sells

Radiology, pathology, teleradiology

Technical snapshotHow the share has been behaving: its momentum, its trend, how much of the trading was real buying to keep, and its returns.

EOD 18 Nov
RSI (14) · 30 oversold, 70 overboughtA score from 0 to 100 showing how strong recent up days were against recent down days.
60.4Neutral
0 oversold3070overbought 100
Delivery · bought to hold vs churnOf all the shares traded in a day, the share that actually changed hands and went into someone's demat account, rather than being bought and sold the same day.
35.3%Below average - weaker conviction
today 35.3%20d avg 93.1%

The share of traded quantity that was actually delivered (not squared off intraday) - high delivery vs its 20-session average suggests real buying or holding, not just churn.

vs 50 DMAHow far today's close is above or below the average closing price of the last 50 trading days. It shows the medium-term trend.+12.5%vs 200 DMAHow far today's close is above or below the average closing price of the last 200 trading days, about ten months. It is the most watched line for the long-term trend.+9.0%1 monthHow much the share price has changed over the period.+11.6%3 monthsHow much the share price has changed over the period.+5.8%Vol 30dHow much the share has actually been moving day to day, stated as a yearly percentage. 30% means it swung roughly 30% a year at that pace.58.8%

Returns and valuationWhat the market pays for this company and how well the business uses its money.

Books to 30 Sept 2026
Market capWhat the whole company is worth on the stock market: share price times the number of shares. It measures size, not quality.₹97 Cr18 NovPrice to bookThe share price against the shareholders' money per share on the balance sheet. It asks what you pay for each rupee the owners have in the business.1.68xbooks of Sept 2026Dividend yieldThe cash paid out in a year as a percentage of today's share price. A 2% yield means ₹2 a year on a ₹100 share.0.00%last 12 monthsDebt to equityBorrowings compared with the shareholders' money. 1 means the company owes as much as its owners have put in; 0 means no borrowings.0.02xbooks of Sept 2026

Shareholding patternThe share of the company held by its promoters, by foreign and domestic institutions, and by the public, quarter by quarter.

Who owns it
66.7%promoter holding, as of 2026-09-30+0.0 pts since 2025
Promoter share since listing
2025-1266.7% now, drawn to its own range2026-09
Who owns it todayas of Sep 26
66.7%
27.5%
Promoter66.7%Foreign (FII)1.5%Domestic (DII)4.3%Public & others27.5%
Who is buying, who is leavingDec 25 to Sep 26
Promoter66.7%steady
Foreign (FII)1.5%+0.6 pts
Domestic (DII)4.3%-6.0 pts

Each line is that holder's share of all shares over the last 3 quarters, drawn to its own scale - the printed change is the size of the move. Mutual funds and insurers sit inside the domestic figure; hover the bar above for that split.

The promoter/promoter-group stake as a percentage of total shares, each quarter since listing. A rising line means promoters are adding to their stake; a falling one often means dilution, pledge-driven sales, or stake sales to new investors.

Recent announcementsThe company's own filings to the exchange in the last six months: results, board meetings, investor calls and more, each with its source document.

Last 6 months
Copy of Newspaper Publication16-Nov-2026

Invicta Diagnostic Limited has informed the Exchange about Copy of Newspaper Publication of the Standalone and Consolidated Unaudited Financial Results of the Company for the half year ended September 30, 2026

Outcome of Board Meeting14-Nov-2026

Invicta Diagnostic Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026.

Outcome of Board Meeting14-Nov-2026

Invicta Diagnostic Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026.

Certificate under SEBI (Depositories and Participants) Regulations, 201809-Oct-2026

Invicta Diagnostic Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended on September 30, 2026

Trading Window28-Sep-2026

Invicta Diagnostic Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

Shareholders meeting19-Sep-2026

Invicta Diagnostic Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on September 19, 2026. Further, the company has informed the Exchange regarding voting results.

Shareholders meeting19-Sep-2026

Invicta Diagnostic Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on September 19, 2026

Outcome of Board Meeting18-Sep-2026

Invicta Diagnostic Limited has informed the Exchange regarding Outcome of Board Meeting held on September 18, 2026 wherein Board considered and approved the proposed business outlook and forward-looking guidance to be communicated by the Chairman & Managing Director and Chief Financial Officer to the Members at the Company s 3rd Annual General Meeting scheduled to be held on Saturday, 19th September, 2026.

Commencement of commercial production/operations17-Sep-2026

Invicta Diagnostic Limited has informed the Exchange about Commencement of commercial operations of Centres at Shegaon Diagnostic LLP (a Subsidiary LLP), and Porteus Pathogenius LLP (a Step-Down Subsidiary LLP)

Copy of Newspaper Publication27-Aug-2026

Invicta Diagnostic Limited has informed the Exchange about Copy of Newspaper Publication of AGM Notice

Shareholders meeting25-Aug-2026

Invicta Diagnostic Limited has informed the Exchange regarding Notice of 3rd Annual General Meeting to be held on September 19, 2026

Outcome of Board Meeting25-Aug-2026

Invicta Diagnostic Limited has informed the Exchange regarding Outcome of Board Meeting held on August 25, 2026.

Resignation of Director/KMP/SMP29-Jul-2026

Invicta Diagnostic Limited has informed the Exchange about Resignation of Director/KMP/SMP

Outcome of Board Meeting29-Jul-2026

Invicta Diagnostic Limited has informed the Exchange regarding Outcome of Board Meeting held on July 29, 2026. Board at its meeting held today1. The Board took on record and accepted the resignation of Mr. Rohit Prakash Srivastava (DIN: 01432112) from the office of Whole-time Director (Finance) and Director of the Company2. The Board accepted the resignation of Ms. Konica Rohit Srivastava from the office of Manager of the Company3. The Board appointed Mr. Sanket Vinod Jain (DIN: 08299039) as Managing Director of the Company 4. The Board approved sale/disposal of the Company's entire stake representing 50% partnership interest in MSCRIBEIT INFOTECH LLP, an associate LLP of the Company5. The Board approved Reconstitution of Stakeholders Relationship Committee

Trading Window23-Jul-2026

Invicta Diagnostic Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

Backtest idea · INVICTAMACD momentum

Momentum turning up, only while the long trend is up.

BuyMACD crosses above signal, price above 200-day SMA
SellMACD crosses back below
Real prices · every charge countedRun on INVICTA
Backtest idea · INVICTALower band bounce

Buys a stretch below the usual range, sells on the way back.

BuyCloses below the lower Bollinger band
SellBack at the middle band, or 15 days
Real prices · every charge countedRun on INVICTA
Backtest idea · INVICTASupertrend rider

Stays in while the trend line says up, out when it flips.

BuySupertrend turns up
SellSupertrend turns down
Real prices · every charge countedRun on INVICTA
Your own ideaWrite a rule for INVICTA in plain English“Buy INVICTA when …”
Start writing
Buy the dip on INVICTABuy when RSI(14) drops below 30
52-week high breakout on INVICTABuy when closes at a 52-week high
Golden cross on INVICTABuy when 50-day EMA crosses above 200-day
Stochastic oversold on INVICTABuy when stochastic %K drops below 20
Pullback in an uptrend on INVICTABuy when RSI(14) below 40, price above 200-day EMA

Key ratios at a glanceThe eight figures most people check first, each placed against companies in the same industry.

Against its sector
Market capWhat the whole company is worth on the stock market: share price times the number of shares. It measures size, not quality.
₹97 cr
Larger than 7% of 15 peers
sector middle ₹1,130 cr
Price to bookThe share price against the shareholders' money per share on the balance sheet. It asks what you pay for each rupee the owners have in the business.
1.7x
Lower than 77% of 13 peers
sector middle 5.4x
Debt to equityBorrowings compared with the shareholders' money. 1 means the company owes as much as its owners have put in; 0 means no borrowings.
0.02
Lower than 62% of 13 peers
sector middle 0.04
Dividend yieldThe cash paid out in a year as a percentage of today's share price. A 2% yield means ₹2 a year on a ₹100 share.
0.0%
Lower than 53% of 15 peers
sector middle 0.1%

Peers are the listed companies in the exchange's own industry group: Healthcare Service Provider. Balance-sheet figures are from the latest filed balance sheet; trends show each financial year we hold.

Backtest idea · INVICTAStochastic oversold

Buys when the close sits near the bottom of its recent range.

BuyStochastic %K drops below 20
Sell8% profit, or after 15 days
Real prices · every charge countedRun on INVICTA
Backtest idea · INVICTAPullback in an uptrend

Buys a pause inside a rising trend.

BuyRSI(14) below 40, price above 200-day EMA
Sell8% profit, or after 30 days
Real prices · every charge countedRun on INVICTA
Backtest idea · INVICTABuy the dip

Buys after a sharp fall, betting on a bounce.

BuyRSI(14) drops below 30
Sell10% profit, or after 20 days
Real prices · every charge countedRun on INVICTA
Backtest idea · INVICTA52-week high breakout

Buys strength, when the price makes a new one-year high.

BuyCloses at a 52-week high
Sell8% stop loss
Real prices · every charge countedRun on INVICTA
Backtest idea · INVICTAGolden cross

Follows the long trend: in when the fast average crosses above the slow one.

Buy50-day EMA crosses above 200-day
SellWhen it crosses back below
Real prices · every charge countedRun on INVICTA
MACD momentum on INVICTABuy when MACD crosses above signal, price above 200-day SMA
Lower band bounce on INVICTABuy when closes below the lower Bollinger band
Supertrend rider on INVICTABuy when supertrend turns up
Buy the dip on INVICTABuy when RSI(14) drops below 30
52-week high breakout on INVICTABuy when closes at a 52-week high

Monthly price changeThe share's price change in every calendar month, one row per year, so you can check for yourself whether a month has a pattern.

Month by month
YearJanFebMarAprMayJunJulAugSepOctNovDecYear
2026
-18.7
-3.9
+1.6
+58.5
-34.1
+1.9
+1.7
+0.6
-1.5
-4.4
+19.4
·
-2.9%
11m
Monthly movebelow -10%-10 to -5-5 to -2-2 to 00 to +2+2 to +5+5 to +10above +10%month in progress

Month-on-month change in closing price, adjusted for splits and bonuses but not for dividends, so a large dividend shows up here as a fall. Starts from 1995, when the exchange began trading equities, or from the stock's listing if later. This is a record of what happened, not a forecast.

Deals and filingsLarge trades reported to the exchange, plus the company's documents sorted by type.

DatePartySideQuantityPriceValue
2026-08-05PINE OAK GLOBAL FUND · bulkSELL1,93,600₹73.79₹1.43 Cr
2026-08-05BIRCHWOOD MULTI STGY FND OPENENDED PCC LTD - BIRCHWOOD GLOBAL ALPHA FUND · bulkBUY1,93,600₹73.79₹1.43 Cr
2026-03-27RGSL INVESTMENT LVF 1 · bulkBUY84,800₹66.00₹0.56 Cr
2026-03-23RGSL INVESTMENT LVF 1 · bulkBUY1,21,600₹67.50₹0.82 Cr
2026-03-19NIHAR AMIT DAVE · bulkBUY1,50,400₹76.00₹1.14 Cr
2026-03-19NEERAJ VISHNUKUMAR GUPTA · bulkSELL1,15,200₹76.00₹0.88 Cr
2026-03-05INVESTI GLOBAL OPPORTUNITY FUND PCC - CELL 1 · bulkBUY1,20,000₹70.44₹0.85 Cr
2026-02-12PINE OAK GLOBAL FUND · bulkBUY1,60,000₹69.00₹1.10 Cr

Read enough? Test INVICTA. “Buy INVICTA when RSI(14) drops below 30, sell at 10% profit or after 20 days.” Real prices, every charge counted.

Run it free